Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Fundamental data now powered by FactSet with hourly updates!

SAVA | Cassava Sciences Inc

IndexRUT P/E- EPS (ttm)-2.19 Insider Own6.19% Shs Outstand41.74M Perf Week-8.33%
Market Cap711.39M Forward P/E- EPS next Y-1.04 Insider Trans1.90% Shs Float39.37M Perf Month-13.12%
Income-90.04M PEG- EPS next Q-0.78 Inst Own28.29% Short Float / Ratio34.81% / 14.69 Perf Quarter-28.69%
Sales0.00M P/S- EPS this Y-52.11% Inst Trans5.25% Short Interest13.70M Perf Half Y-27.75%
Book/sh4.28 P/B3.96 EPS next Y63.84% ROA-42.41% Target Price112.00 Perf Year-62.49%
Cash/sh4.01 P/C4.22 EPS next 5Y- ROE-45.28% 52W Range16.55 - 50.77 Perf YTD-42.62%
Dividend- P/FCF- EPS past 5Y-0.83% ROI-50.20% 52W High-66.61% Beta0.03
Dividend %- Quick Ratio9.75 Sales past 5Y0.00% Gross Margin- 52W Low2.42% ATR1.00
Employees26 Current Ratio9.75 Sales Q/Q- Oper. Margin0.00% RSI (14)33.24 Volatility4.21% 5.65%
OptionableYes Debt/Eq0.00 EPS Q/Q-30.66% Profit Margin- Rel Volume0.58 Prev Close17.07
ShortableYes LT Debt/Eq0.00 EarningsAug 03 BMO Payout- Avg Volume933.18K Price16.95
Recom1.00 SMA20-13.69% SMA50-13.00% SMA200-32.03% Volume541,057 Change-0.70%
Date Action Analyst Rating Change Price Target Change
Nov-16-22Downgrade B. Riley Securities Buy → Neutral $44
Jul-15-21Downgrade Cantor Fitzgerald Overweight → Neutral $100
Jul-07-21Reiterated Maxim Group Buy $80 → $190
Apr-27-21Initiated B. Riley Securities Buy $78
Feb-16-21Reiterated H.C. Wainwright Buy $20 → $66
Oct-23-20Initiated Cantor Fitzgerald Overweight $24
Sep-23-20Upgrade H.C. Wainwright Neutral → Buy $20
May-18-20Downgrade H.C. Wainwright Buy → Neutral
May-15-20Downgrade Maxim Group Buy → Hold
Jan-10-20Reiterated Maxim Group Buy $3 → $12
Sep-18-23 09:15AM
Sep-14-23 06:30AM
Sep-13-23 05:20PM
Sep-11-23 09:10AM
Sep-06-23 09:15AM
07:30AM Loading…
Aug-29-23 07:30AM
Aug-03-23 09:07AM
Jul-29-23 11:30AM
Jul-13-23 07:31AM
Jul-05-23 11:44AM
Jun-27-23 09:15AM
Jun-12-23 10:19AM
Jun-01-23 09:15AM
12:06PM Loading…
May-30-23 12:06PM
May-23-23 09:50AM
May-12-23 04:39PM
May-11-23 02:40PM
May-08-23 09:15AM
May-01-23 09:00AM
Apr-26-23 09:12AM
Mar-09-23 09:45AM
Mar-04-23 07:20AM
Mar-03-23 07:07AM
Feb-28-23 09:15AM
Feb-24-23 01:29PM
Feb-08-23 09:15AM
Feb-01-23 08:55AM
08:27PM Loading…
Jan-25-23 08:27PM
Jan-24-23 04:06PM
Jan-18-23 10:35AM
Jan-12-23 09:40AM
Jan-03-23 09:16AM
Dec-20-22 09:15AM
Dec-06-22 09:15AM
Nov-22-22 12:30PM
Nov-18-22 01:30PM
Nov-16-22 10:43AM
Nov-15-22 10:00AM
Nov-14-22 03:54PM
Nov-07-22 09:00AM
Nov-04-22 10:49AM
Nov-03-22 09:15AM
Nov-01-22 02:21PM
Oct-31-22 05:50PM
Oct-27-22 09:15AM
Oct-25-22 05:50PM
Oct-17-22 05:50PM
Oct-13-22 09:15AM
Oct-11-22 06:00PM
Oct-05-22 06:15AM
Sep-30-22 10:35AM
Sep-29-22 06:15PM
Sep-27-22 01:11PM
Sep-23-22 04:11PM
Sep-16-22 06:15PM
Sep-09-22 12:08PM
Sep-08-22 09:15AM
Sep-05-22 08:01PM
Aug-18-22 01:06PM
Aug-17-22 01:40PM
Aug-16-22 06:09PM
Aug-03-22 09:15AM
Jul-29-22 01:29PM
Jul-27-22 02:58PM
Jul-26-22 06:15PM
Jul-24-22 10:00AM
Jun-24-22 06:15PM
Jun-16-22 06:15PM
May-25-22 11:32AM
May-05-22 09:00AM
May-04-22 08:48AM
Apr-29-22 02:40PM
Apr-28-22 05:50PM
Apr-26-22 03:03PM
Apr-25-22 03:11PM
Apr-19-22 03:17PM
Apr-15-22 09:30AM
Apr-14-22 07:14PM
Apr-11-22 05:04PM
Apr-08-22 08:59AM
Apr-07-22 05:29PM
Apr-06-22 06:11PM
Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer's disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier in May 1998 and is headquartered in Austin, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ROBERTSON SANFORDDirectorAug 23Buy17.4530,000523,500886,851Aug 24 04:06 PM
Barry RichardDirectorAug 22Buy16.6516,571275,907293,477Aug 23 04:58 PM
Barry RichardDirectorAug 21Buy16.801,90632,021276,906Aug 23 04:58 PM
SCANNON PATRICK J MD PHDDirectorJun 12Option Exercise0.951,0009501,000Jun 12 04:53 PM
BARBIER REMIPresident and CEOMay 24Option Exercise16.8771,4281,204,990782,002May 25 05:11 PM
BARBIER REMIPresident and CEOMay 24Option Exercise16.8714,285240,988390,397May 25 05:11 PM
ROBERTSON SANFORDDirectorMay 10Option Exercise17.799,284165,170856,851May 10 04:08 PM
GUSSIN ROBERT ZDirectorMay 01Option Exercise17.799,284165,17017,694May 02 04:04 PM
O DONNELL MICHAEL JDirectorMar 07Option Exercise18.137,142129,48412,012Mar 08 04:12 PM
Barry RichardDirectorMar 07Buy25.7677,2761,990,630275,000Mar 08 04:07 PM
Barry RichardDirectorMar 06Buy26.1311,565302,193197,724Mar 08 04:07 PM
FRIEDMANN NADAVChief Medical OfficerOct 03Option Exercise0.959,3768,90779,910Oct 03 06:01 PM